Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lesaka Technologies (LSAK) Asset Writedowns and Impairment (2017 - 2025)

Lesaka Technologies (LSAK) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $18.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Writedowns and Impairment rose 7445.2% year-over-year to $18.9 million, compared with a TTM value of $18.9 million through Jun 2025, changed N/A, and an annual FY2025 reading of $18.9 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $18.9 million for Q2 2025 at Lesaka Technologies, up from $250000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $18.9 million in Q2 2025 and bottomed at -$250000.0 in Q3 2023.
  • Average Asset Writedowns and Impairment over 5 years is $3.3 million, with a median of $140000.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 102.82% in 2022, then skyrocketed 7445.2% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $140000.0 in 2021, then crashed by 180.71% to -$113000.0 in 2022, then plummeted by 121.24% to -$250000.0 in 2023, then skyrocketed by 200.0% to $250000.0 in 2024, then surged by 7445.2% to $18.9 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for LSAK at $18.9 million in Q2 2025, $250000.0 in Q2 2024, and -$250000.0 in Q3 2023.